Natural Gene Therapy for Intractable Skin Disease Identified: Study

Natural gene therapy can offer fresh hope for patients with an intractable skin disease known as Loricrin keratoderma (LK), reveals a new study.

Natural gene therapy can offer fresh hope for patients with intractable skin disease, reports a new study. The findings of the study are published in the journal Life Science Alliance.

Pathogenic gene mutations causing a type of //intractable skin disease can be eliminated from some parts of patients' skin as they age, according to Hokkaido University researchers and their collaborators in Japan. This represents a form of natural gene therapy.

Painful but Effective Treatment for Skin Diseases
Medications that block both ion channels is effective in reducing pain and inflammation though the procedure discourages patients for further therapy.

‘Natural gene therapy discovered can be used to treat a type of intractable skin disease known as Loricrin keratoderma (LK) by eliminating the disease-causing pathogenic gene mutations from some parts of patients' skin as they age.’

In general, there is no fundamental treatment method capable of curing diseases caused by gene abnormality because it is difficult to remove certain genetic mutations from all affected cells. Loricrin keratoderma (LK) is one such disease; caused by loricrin mutations, it is characterized by dry, thickened, scaly skin from birth. Only symptomatic treatments are available to alleviate the conditions, which cause difficulties in patients' daily lives. Thus far, doctors have not known how to treat the ailment.

In a study, the research team, including Toshifumi Nomura and Shotaro Suzuki of Hokkaido University, observed the patients' skin for an extended period. They discovered that LK patients had normal-looking skin areas dotted around their body. Tissue from those areas was examined for histology, and DNA extracted from both the epidermis and dermis were checked for loricrin mutations.

The study found skin areas that looked normal were in fact skin that had returned to normal and that, surprisingly, the mutant loricrin which patients were supposed to have from birth had disappeared. Detailed analyses of the DNA sequences revealed that the mutation had disappeared due to somatic recombination -- a type of DNA recombination that causes exchange of DNA strands that contain similar sequences¬¬. Normal skin stayed in the same location for at least several years, so the finding suggests gene mutations are eliminated from stem cells that keep providing new cells in the epidermis.

Gene Therapy Could Cure Osteoarthritis by Rejuvenating Aging Cells
Scientists have found that a protein factor called CBX4, could help to cure osteoarthritis in mice by rejuvenation of aging cells.

The study also found that cells with normal loricrin have higher reproduction ability and are more likely to form colonies than cells with mutant loricrin. This survival advantage could be why the normal cells became noticeable on the patients' skin.

"If we could elucidate the mechanism of frequent somatic recombination occurring in epidermal cells, and could find a way to artificially induce it, that could lead to the development of a new treatment method for loricrin keratoderma, and potentially other genetic diseases," says Toshifumi Nomura.

New Gene Therapy Approach to Tackle Inherited Genetic Diseases
A new study reveals a novel approach and robust technology platform for suppressing nonsense mutations using engineered transfer RNA (tRNA) molecules.

Source-Eurekalert

Gene Therapy for Macular Degeneration
Gene therapy gives new hope for age-related blindness. Scientists were able to deliver the gene for a retinal opsin into the genome of ganglion cells using an adeno-associated viral vector. The blind ganglion cells were restored and became sensitive to light.